Close Menu

digital PCR

The company filed to go public in March with plans to offer up to $60 million of its stock. 

The firm said that it plans to list its stock on the Nasdaq under ticker symbol "RAIN" and added that its 2014 revenues were up 78 percent year over year to $30.6 million.

The new RUO application for the company's QuantStudio 3D Digital PCR platform is designed to enable researchers to accurately phenotype the CYP2D6 gene, a key indicator of drug metabolism.

NEW YORK (GenomeWeb) – Fitch Ratings today affirmed the ratings of Bio-Rad Laboratories, including the issuer default rating, at BBB- .

NEW YORK (GenomeWeb) ― Manipulating miniature droplets and subjecting them to high temperatures on an open digital microfluidic device leads to evaporation that can seriously disrupt concentration-dependent enzymatic reactions, like PCR.

NEW YORK (GenomeWeb) — Seattle-based start-up Lamprogen, a spinout of the University of Washington, is using funding from two grants to further the development of a self-digitizing microfluidic chip and instrument on which the chip will run.

NEW YORK (GenomeWeb) — Virologists at the University of Washington and the Fred Hutchinson Cancer Research Center recently reported that in a small, retrospective study droplet digital PCR appeared to have no added benefit over qPCR for clinical monitoring of human cytomegalovirus load in transpl

NEW YORK (GenomeWeb) — Researchers from Virginia Commonwealth University have developed a method of quantifying multiple nucleic acid targets in a single sample by combining low-cycle-number, target-specific PCR with atomic force microscopy.

NEW YORK (GenomeWeb) — RUCDR Infinite Biologics, the research services and biorepository arm of the Rutgers University Cell and DNA Repository (RUCDR), has been named a RainDance Technologies Center of Excellence, the partners said this week.

NEW YORK (GenomeWeb) — RUCDR Infinite Biologics, the research services and biorepository arm of the Rutgers University Cell and DNA Repository (RUCDR), has been named a RainDance Technologies Center of Excellence, the partners said today.

Pages

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.